209 related articles for article (PubMed ID: 22956728)
1. Cervical cancer burden and prevention activities in Europe.
Kesic V; Poljak M; Rogovskaya S
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1423-33. PubMed ID: 22956728
[TBL] [Abstract][Full Text] [Related]
2. Introduction of human papillomavirus vaccination in Nordic countries.
Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer burden and prevention strategies: Asia Oceania perspective.
Garland SM; Bhatla N; Ngan HY
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1414-22. PubMed ID: 22956727
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer as a public health issue--what next?
Corusić A; Skrgatić L; Mahovlić V; Mandić V; Planinić P; Karadza M
Coll Antropol; 2010 Mar; 34(1):301-7. PubMed ID: 20432764
[TBL] [Abstract][Full Text] [Related]
5. European consensus statement on "HPV Vaccination and Colposcopy".
Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer in Latin America and the Caribbean: the problem and the way to solutions.
Villa LL
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1409-13. PubMed ID: 22956726
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.
Franco EL; Ferenczy A
Future Oncol; 2007 Jun; 3(3):319-27. PubMed ID: 17547527
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
10. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
[TBL] [Abstract][Full Text] [Related]
11. Primary and secondary prevention of cervical cancer.
Grce M
Expert Rev Mol Diagn; 2009 Nov; 9(8):851-7. PubMed ID: 19895230
[TBL] [Abstract][Full Text] [Related]
12. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer in the human papillomavirus vaccination era.
Tay SK
Curr Opin Obstet Gynecol; 2012 Feb; 24(1):3-7. PubMed ID: 22123221
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
[TBL] [Abstract][Full Text] [Related]
16. Vaccines against human papillomavirus: perspectives for controlling cervical cancer.
García Carrancá A; Galván SC
Expert Rev Vaccines; 2007 Aug; 6(4):497-510. PubMed ID: 17669005
[TBL] [Abstract][Full Text] [Related]
17. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia.
Obradovic M; Mrhar A; Kos M
Eur J Public Health; 2010 Aug; 20(4):415-21. PubMed ID: 20624834
[TBL] [Abstract][Full Text] [Related]
19. The role of the human papillomavirus (HPV) vaccine in developing countries.
Kling M; Zeichner JA
Int J Dermatol; 2010 Apr; 49(4):377-9. PubMed ID: 20465688
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
